|
CAI Caris Life Sciences Inc 2019410 |
| Balance Sheet |
|
Current Assets
|
$1,014,180,000.00 |
|
Assets
|
$1,162,388,000.00 |
|
Current Liabilities
|
$143,896,000.00 |
|
Liabilities
|
$568,898,000.00 |
|
Equity
|
$593,490,000.00 |
|
Shares Out
|
282650723.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$32,876,000.00 |
|
Investing Cash Flow
|
$-10,342,000.00 |
| Market Analysis |
Market Cap
|
$4,547,850,133.07 |
|
Price
|
$16.54 |
|
BVPS
|
2.10 |
|
PB
|
7.66 |
|
PS
|
5.98 |
|
FCF
|
$22,534,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:19 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:13 |
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
0.28 |
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
0.00 |
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-7.97 |
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
0.08 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CAI documents filed with the SEC.
CAI Filings
Clear